Angela Belcher delivers 2023 Dresselhaus Lecture on evolving organisms for new nanomaterials
MIT professor combines nanoscience and viruses to develop solutions in energy, environment, and medicine.
Koch Institute
3 Questions: Darrell Irvine on making HIV vaccines more powerful
Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.
Immune action at a distance
MIT and MGH researchers design a local, gel-based drug-delivery platform that may provoke a system-wide immune response to metastatic tumors.
A new way to see the activity inside a living cell
Using fluorescent labels that switch on and off, MIT engineers can study how molecules in a cell interact to control the cell’s behavior.
Gitanjali Rao honored at White House “Girls Leading Change” celebration
First-year MIT student and former Time “Kid of the Year” honored for promoting science and innovation among youth and inspiring them with several inventions.
Ingestible electronic device detects breathing depression in patients
The new sensor measures heart and breathing rate from patients with sleep apnea and could also be used to monitor people at risk of opioid overdose.
Gene-Wei Li and Michael Birnbaum named Pew Innovation Fund investigators
MIT researchers will partner on interdisciplinary research in human biology and disease.
Studying cancer in context to stop its growth
MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new drug targets.
An implantable device could enable injection-free control of diabetes
The device contains encapsulated cells that produce insulin, plus a tiny oxygen-producing factory that keeps the cells healthy.
Study explains why certain immunotherapies don’t always work as predicted
The findings could help doctors identify cancer patients who would benefit the most from drugs called checkpoint blockade inhibitors.
Smart pill can track key biological markers in real-time
Coupling engineered bacteria with low-power electronics could be highly effective in diagnosis, treatment of bowel diseases.
MIT engineers design more powerful RNA vaccines
The new approach could lead to intranasal vaccines for Covid-19 and other respiratory diseases.
The tenured engineers of 2023
Nine faculty members have been granted tenure in six units across MIT’s School of Engineering.
A snapshot of cancer vaccine development
The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.
Fourteen MIT School of Science professors receive tenure for 2022 and 2023
Faculty members were recently granted tenure in the departments of Biology, Brain and Cognitive Sciences, Chemistry, EAPS, and Physics.